Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ER+HER2- Breast Cancer × 18-O-demethylcervinomycin A2 × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 ER+HER2- Breast Cancer 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

18-O-demethylcervinomycin A2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡